NewsRx

Search our medical news database

At-Risk Populations

Validation of Recommendations for Pneumococcal Vaccination of HIV+ People

Published in Vaccine Weekly, June 17th, 1996

People with HIV infection who respond to pneumococcal vaccine develop protective immunity, but it is useless to revaccinate nonresponders.

These findings validate current U.S. Centers for Disease Control and Prevention (CDC) recommendations that people with HIV infection should receive the 23-valent pneumococcal polysaccharide (PPS) vaccine (Pnu-Imune; Lederle, West Henrietta, New York).

Maria C. Rodriguez-Barradas of the VA Medical center, Houston, Texas, and colleagues, studied the response to PPS vaccine in 104 patients with HIV infection treated at their facility.

They reported their findings in the Journal of Infectious...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook